London
6 °C
Manchester
Glasgow
Dublin
Belfast
Washington
Denver
Atlanta
12 °C
Dallas
Houston Texas
22 °C
New Orleans
El Paso
Phoenix
Los Angeles
-14 °C
-13 °C
2 °C
22 °C
26 °C
27 °C
14 °C
Featured
Last news
Unusual Machines to Supply Campus Guardian Angel with U.S.-Made Drone Components
Order underscores the growing role of rapid-response drone technology in strengthening school emergency response capabilities
GameSquare Announces 1,038,787 Shares Repurchase
FRISCO, TEXAS / ACCESS Newswire / December 12, 2025 / GameSquare Holdings, Inc. ("GameSquare" or the "Company") a next-generation media, entertainment, technology and digital native treasury company, today announced it repurchased 1,038,787 shares of its common stock for $563,801, representing an average price of approximately $0.54 per share. Following this transaction, the Company has approximately $3.3 million remaining under its current authorization.
Aible Showcases Automated AI Agents to Manage Business Volatility with NVIDIA and HPE
Aible exhibited in NVIDIA's booths at HPE Discover Barcelona and AWS Re:InventDemonstrating Aible running air-gapped on NVIDIA DGX Spark, creating agents that can then be published to AWS to run serverless at scale or to HPE ProLiant Compute servers and HPE Private Cloud AI to run on private cloudKey use cases include automated trend analytics that sift through millions of data patterns to pinpoint critical changes in customer purchase, spend, and inventory lifecycles
Make your own Mickey Mouse clip - Disney embraces AI
Walt Disney and OpenAI announced a three-year licensing deal Thursday that will allow users to create short videos featuring beloved Disney characters through artificial intelligence.
Make your own AI Mickey Mouse - Disney embraces new tech
Walt Disney and OpenAI announced a three-year licensing deal Thursday that will allow users to create short videos featuring beloved Disney characters through artificial intelligence.
LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies
VANCOUVER, BC / ACCESS Newswire / December 11, 2025 / LIR Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("LIR" or the "Company") announces that it has filed a provisional patent application intended to cover a needle-free delivery platform for GLP/GIP[1]-based therapies used in obesity and metabolic disease. LIR filed the provisional patent application titled "Transdermal and Lingual Delivery System for GLP-1 Inhibitors" with the United States Patent and Trademark Office (USPTO). The filing is intended to protect LIR's approach to delivering these therapies through the skin, with the goal of replacing or reducing the need for injections.
A2Z Cust2Mate Expands Leadership Team to Accelerate Global Growth
Morrison and d'Avezac to Spearhead Smart Cart Sales Across American and European Markets
Oil-rich UAE turns to AI to grease economy
Deep in the Abu Dhabi desert, a vast AI campus a quarter the size of Paris is starting to emerge, the oil-rich UAE's boldest bet yet on technology it hopes will help transform its economy.
A2Z Cust2Mate to Host Investor Virtual Meeting on Tuesday, December 16, 2025
Institutional investors are invited to hear the company share recent milestones and its long-term strategic roadmap
DataMetrex Signs Definitive Agreement to Acquire Yuzu Payment Processing Solution From Firstpayment Inc.
TORONTO, ONTARIO / ACCESS Newswire / December 10, 2025 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce further to its news releases dated September 15, 2025, September 22, 2025, September 29, 2025 November 11, 2025 and November 14, 2025, it has signed a definitive asset purchase agreement, dated December 9, 2025 (the "Definitive Agreement") to acquire via a wholly owned subsidiary, Paymetrex Payment Solutions Inc, ("Paymetrex") the Yuzu payment processing solution from Firstpayment Inc. ("Firstpayment"), a Canadian-based fintech company, including the related patents and intellectual property (the "Yuzu Payment Solution") in an arm's length transaction (the "Transaction").
TIS Helps Treasury Teams Navigate the Ongoing ISO 20022 Transition After the 2025 Banking Deadline
BERLIN, DE / ACCESS Newswire / December 10, 2025 / Treasury Intelligence Solutions (TIS), a leading cloud-based platform for payments and cash management, is future-proofing organizations with specialized translation services in the wake of the recent November 2025 ISO 20022 deadline. A major turning point for the financial industry, SWIFT now requires banks to move their cross-border payment messages to ISO 20022. As a result, treasury teams are already seeing differences in how their banks send and receive payment information. Adapting to these changes will require a strategic approach to modernizing systems and processes.
ShelfieTech Provides Corporate Update
TEL AVIV, IL / ACCESS Newswire / December 10, 2025 / Shelfie-Tech Ltd. (CSE:SHLF)(OTCQB:$SHLFF) ("ShelfieTech", or the "Company") a technology innovator in retail automation and AI-driven in-store intelligence solutions, is pleased to release a corporate update highlighting the Company's achievements in 2025.
Lir Life Sciences Completes Design of a Comparative Animal Study Investigating Cell-Penetrating Peptide-Mediated Delivery of GLP/GIP-Based Obesity Therapies
VANCOUVER, BC / ACCESS Newswire / December 10, 2025 / Lir Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("Lir" or the "Company") is pleased to announce the design of a new comparative cell-penetrating peptide-based uptake study (the "Study") of GLP/GIP[1]-based obesity therapies, further advancing its novel transdermal platform for obesity and metabolic disease. This initiative is intended to further the Company's research and development of patient-friendly, needle-free delivery options for incretin therapies. The Company believes that transdermal systems have the potential to improve comfort, accessibility, and long-term treatment adherence for individuals managing chronic metabolic conditions and evidence-based weight-loss treatments.
Canada launches billion dollar plan to recruit top researchers
Canada on Tuesday launched a CAN$1.7 billion ($1.2 billion) program to recruit leading global researchers, part of the effort to poach intellectual talent looking to leave the United States because of President Donald Trump's policies.
Astronomers detect cosmic flash from early universe star blast
An immensely powerful flash detected earlier this year was created by a massive star exploding when the universe was just five percent of its current age, astronomers said Tuesday.
South Korea's president begins move back to historic Blue House
South Korea's president and his team have started moving back into Seoul's historic Blue House, which his predecessor abandoned for being too "imperial", an official said Tuesday.
Data centers: a view from the inside
The expansion of data centers to power the AI boom has more people wondering: what exactly is in a data center?
Nextech3D.ai to Acquire Krafty Labs, Expanding AI Event Solutions for Enterprise Clients
Krafty Labs Generated 2025 Year to date Revenue of $1.1 mill with a 72% gross marginAll-Cash Deal for $600,000Acquiring a Blue Chip customers list; Google, Meta, Oracle etcNextech3d.ai Doubles Customer Base to 1000+Nextech3d.ai is Accelerating its Growth As a One-Stop AI Event Tech Suite
e& Selects Amdocs to Power Its Generative AI Experiences
Leveraging Amdocs' amAIz - generative AI Platform and its agents, powered by NVIDIA AI Enterprise, e& UAE is integrating generative AI into its business processes, opening possibilities for new revenue opportunities, business efficiencies, and improved customer experiences
Trump says to sign order blocking AI regulation by states
President Donald Trump said Monday he will attempt to strip states of the right to regulate the surging AI industry, arguing centralized rulemaking is vital to maintain US dominance.
AI tools help choose best embryos for IVF
Artificial intelligence tools can now help choose the most promising embryos for in vitro fertilisation (IVF), although experts have warned of some ethical concerns.
Snaplii Reminds Shoppers of Special Cashback Offers During Holiday Season
It's the last call for the smart shopping app's holiday promotions, which provide increasing cashback rewards at spending milestones and offer double cashback rewards on select brands through Monday, Dec. 15.
Additional Positive Results for Omisirge(R) in Treating Severe Aplastic Anemia Presented at ASH
New data presented at the 2025 ASH demonstrates 94% disease free and overall survival rateOmisirge approved by FDA as First Cell Therapy to Treat Severe Aplastic AnemiaKey Highlights of Data Presented at ASH:95% of patients achieved rapid neutrophil recoveryMedian time to neutrophil recovery: 8 daysImmune recovery post-transplant was rapid94% disease-free and overall survivalNo cases of BMT-CTN severe acute graft-versus-host disease (GVHD), or chronic GVHD observedOmisirge approved by the FDA on December 5, 2025 for SAA
Ayrmid Presents New Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease
Motixafortide alone and in combination with natalizumab can support the collection of the large number of stem cells required by gene therapies for sickle cell disease within a single apheresis cycleKey HighlightsMotixafortide alone and in combination with natalizumab (VLA-4 inhibitor) led to robust hematopoietic stem cell (HSC) mobilization predicting 16.9 million and 19.6 million cells/kg collected in a single apheresis session.Motixafortide alone and in combination with natalizumab mobilized 2.7 and 2.8 fold greater HSCs, relative to plerixaforResults support the use of motixafortide as an effective single-agent mobilizer of HSCs for people with sickle cell disease enabling accelerated access to gene therapiesData from study shows that motixafortide was safe and well toleratedFindings presented at ASH 2025
Greenlane Buys $8 Million worth of BERA, Maintains Approximately $32 Million Cash and Stablecoin Reserves for Berachain Treasury Strategy
BOCA RATON, FL / ACCESS Newswire / December 8, 2025 / Greenlane Holdings, Inc. ("Greenlane" or the "Company") (Nasdaq:GNLN), a Berachain-focused digital asset treasury company and global seller of premium cannabis accessories, and subsequent to the Company's press releases issued on October 24, 2025 and November 14, 2025 that disclosed Greenlane's Berachain cryptocurrency treasury strategy (the "Berachain Treasury Strategy"), is providing an update on its BERA token holdings, staking activity, and capital position related to its participation in the Berachain ecosystem.
Unusual Machines and Dynamic Aerospace Systems Enter Supplier Agreement for U.S.-Made, NDAA-Compliant Drone Components
Partnership supports DAS's expanding commercial logistics operations in the Middle East and Europe
QNX to Showcase Innovations for Software-Defined Vehicles and Mission-Critical Embedded Systems at CES 2026
WATERLOO, ONTARIO / ACCESS Newswire / December 8, 2025 / QNX, a division of BlackBerry Limited (NYSE:BB)(TSX:BB), has announced it will showcase the latest advancements in its mission-critical embedded systems and automotive software product portfolio, including a new demo of its Foundational Vehicle Software Platform developed in collaboration with Vector, at CES 2026.
Ayrmid Reports Promising New Real-World Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease
Key HighlightsMotixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease enabling accelerated access to gene therapies90% (9 of 10) of patients were able to collect sufficient HSC to enable progress to gene therapy manufacturing86% (6 of 7) of patients had previously failed to collect sufficient cells with plerixaforResults support the use of motixafortide as an effective single-agent mobilizer of HSC for people with sickle cell disease for gene therapiesFindings presented at ASH 2025
Meta partners with news outlets to expand AI content
Meta announced Friday it will integrate content from major news organizations into its artificial intelligence assistant to provide Facebook, Instagram and WhatsApp users with real-time information.
Softbank's Son says super AI could make humans like fish, win Nobel Prize
Softbank CEO and AI investor Masayoshi Son said Friday that advanced artificial intelligence could surpass humans to the extent that "we become fish" and could even win the Nobel Prize in Literature.
FDA approves Omisirge(R) as First Approved Cell Therapy to Treat Severe Aplastic Anemia
Study demonstrated early and sustained hematopoietic recovery and transfusion independenceOmisirge is a new and novel transplant option for patients with SAAAdditional manufacturing capacity for Omisirge will be established in the U.S.Represents a supplementary FDA approval for Omisirge
NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
QUEBEC, QC / ACCESS Newswire / December 5, 2025 / NuRAN Wireless Inc. ("NuRAN" or the "Company") (CSE:NUR)(OTC:NRRWF)(FSE:1RN), a leading provider of mobile and broadband wireless infrastructure, announces that the board of directors of the Company (the "Board") has approved a consolidation of its issued and outstanding common shares ("Common Shares") on the basis of one post-consolidated Common Share for every three hundred (300) pre-consolidated Common Shares (the "Consolidation"). This Consolidation was approved by the Company's shareholders at the shareholders meeting held on October 22, 2025, where shareholder approval was given to undertake a consolidation of the Company's Common Shares at a ratio to be determined by the Board, at its sole discretion, to permit the Corporation to satisfy all conditions and necessary regulatory approvals to list the Common Shares on the NASDAQ, NYSE or such other U.S. national securities exchange as the Board may determine in its sole discretion.